Clinical trial

Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

NCT03927391

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-05-30

PhasePHASE4

Study timeline

Study start (actual)2019-05-30Date precision: day

Registry last updated2024-06-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostatic Neoplasms, Castration-Resistantunresolved

Interventions

EnzalutamideDRUG · verified · RxNorm: enzalutamide

Sponsors & collaborators

Radboud University Medical Centerlead sponsor

Mapped research locations

NijmegenNetherlands2 RotterdamNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03927391 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.